Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of growth hormone on pregnancy outcomes in recurrent implantation failure
IRCT20091012002576N34Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of somatropin in infertility and Recurrent Implantation Failure (RIF), sponsored by Tehran University of Medical Sciences. Started Oct 2023; status: completed.
02
Drugs
somatropin
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20091012002576N34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N34.